Clinitech Laboratory IPO Financials
The Clinitech Laboratory IPO provide an overview of the company's performance over the previous financial periods. Investors can evaluate key financial metrics such as assets, revenue, profit after tax (PAT), net worth, reserves & surplus, and total borrowings to assess the company's financial strength, profitability, and long-term growth potential before investing in the IPO.
As of 31 Mar 2024, Clinitech Laboratory Limited reported assets of ₹560.79 crore, revenue of ₹643.92 crore, and a profit after tax (PAT) of ₹37.12 crore. The company had a net worth of ₹354.8 crore and reserves & surplus of ₹186.8 crore, and total borrowings are 86.31 crore.
Revenue increased by 40.48% in 31 Mar 2022 and decreased by 1.45% in 31 Mar 2023 and increased by 1.19% in 31 Mar 2024 , while Profit After Tax (PAT) grew by 27.39% in 31 Mar 2022 and grew by 19.61% in 31 Mar 2023 and declined by 39.46% in 31 Mar 2024 , respectively.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Clinitech Laboratory Limited Financials (₹ in Crores)
| Particular | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 560.79 | 603.33 | 368.74 | 273.32 |
| Revenue | 643.92 | 636.34 | 645.7 | 459.63 |
| Profit After Tax | 37.12 | 61.31 | 51.26 | 40.24 |
| Net Worth | 354.8 | 238.08 | 184.81 | 139.03 |
| Reserve & Surplus | 186.8 | 88.08 | 34.81 | 72.37 |
| Total Borrowings | 86.31 | 102.91 | 88.61 | 53.67 |
EPS Pre
2.21%
EPS Post
1.63%
P/E Pre
43.45
P/E (Post Issue)
59.03x
Company Financial Information
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Revenue of Clinitech Laboratory Limited?
Clinitech Laboratory Limited reported revenue of ₹643.92 crore as of 31 Mar 2024 . Revenue figures from the Clinitech Laboratory IPO provide insights into sales growth, market demand, and business scalability.
What is the Profit After Tax (PAT) of Clinitech Laboratory Limited?
Clinitech Laboratory Limited reported a Profit After Tax (PAT) of ₹37.12 crore as of 31 Mar 2024 . PAT represents the company's net profit after deducting all operating expenses, interest, taxes, and other applicable charges, making it a key indicator of overall profitability.
What is the PE Ratio of Clinitech Laboratory Limited?
Clinitech Laboratory Limited has a Price-to-Earnings (P/E) ratio of 43.45x based on the IPO issue price. The P/E ratio compares the company's share price with its earnings per share (EPS) and is a commonly used valuation metric to assess whether a stock is fairly valued relative to its earnings and industry peers.